Overview
Analog based drug design (ABDD) is a promising technique for developing new drugs in the field of advanced pharmaceutical science and technology. The concept behind ABDD is to design new drugs based on the molecular structure and properties of existing drugs that have been previously approved by the FDA. In ABDD, the drug designer uses computational techniques to identify compounds with similar chemical structures and properties as the existing drug. The designer then modifies the existing compound to improve its efficacy, bioavailability, and safety. By starting with a known compound, the development process of the new drug can be more efficient and cost-effective. The use of ABDD has had remarkable success in developing new drugs for the treatment of various diseases, including cancer, infections, and cardiovascular diseases. It has led to the development of new classes of drugs, such as protease inhibitors and statins. ABDD can be used in combination with other techniques, such as high-throughput screening and rational drug design, to accelerate the drug discovery process. This integrated approach has great potential for the future development of new drugs. In conclusion, analog based drug design is a powerful tool in the field of advanced pharmaceutical science and technology. By using ABDD, drug designers can develop new drugs more efficiently and effectively, leading to better treatment options for patients.